Minimization protocols in pancreas transplantation

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Transplant International

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2008.00738.xPMID 18713147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Hyperglycaemia After Pancreas Transplantation

  2012cited by this paper
• Anti-human leukocyte antigen antibodies after islet transplantation: what do they really mean?

  2008cited by this paper
• The first Joint Conference of the Cell Transplant Society (CTS), International Pancreas and Islet Transplant Association (IPITA), and International Xenotransplantation Association (IXA), all sections of The Transplantation Society (TTS), took place in Minneapolis, Minn, USA, from September 15-20, 20

  2008cited by this paper
• Kidney Transplantation—Second Edition

  2008cited by this paper
• Banff Schema for Grading Pancreas Allograft Rejection: Working Proposal by a Multi‐Disciplinary International Consensus Panel

  2008cited by this paper
• Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?

  2008cited by this paper
• Alemtuzumab (Campath‐1H) in Kidney Transplantation

  2007cited by this paper
• Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Simultaneous Pancreas‐Kidney Transplantation Comparison With Rabbit Antithymocyte Globulin Induction – Long‐Term Results

  2006cited by this paper
• The evolving role of alemtuzumab (Campath‐1H) for immunosuppressive therapy in organ transplantation

  2006cited by this paper
• Immunosuppression: Evolution in Practice and Trends, 1994–2004

  2006influential reference
• Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study.

  2005cited by this paper
• PANCREAS TRANSPLANT ALONE IMPROVES DIABETIC NEPHROPATHY

  2005cited by this paper
• Pancreas transplant outcomes for United States (US) and non‐US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004

  2005cited by this paper
• Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years

  2005cited by this paper
• Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation

  2005cited by this paper
• BKV in Simultaneous Pancreas‐Kidney Transplant Recipients: A Leading Cause of Renal Graft Loss in First 2 Years Post‐Transplant

  2005cited by this paper
• An Evidence‐Based Analysis of Simultaneous Pancreas‐Kidney and Pancreas Transplantation Alone

  2005cited by this paper
• A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.

  2005cited by this paper
• Immunobiology, Diagnosis, and Treatment of Pancreas Graft Rejection

  2004cited by this paper
• PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1

  2004cited by this paper
• EFFICACY AND SAFETY OF TACROLIMUS COMPARED WITH CYCLOSPORINE MICROEMULSION IN PRIMARY SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: 1-YEAR RESULTS OF A LARGE MULTICENTER TRIAL

  2004cited by this paper
• Improving results in solitary pancreas transplantation with portal‐enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil‐based immunosuppression

  2003cited by this paper
• Immunosuppression: practice and trends

  2003influential reference
• Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression

  2003cited by this paper
• Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1

  2003cited by this paper
• Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.

  2001cited by this paper
• Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation

  2001cited by this paper
• Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage.

  2000cited by this paper
• Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.

  2000cited by this paper
• A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.

  1998cited by this paper
• Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.

  1998cited by this paper
• Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.

  1997influential reference
• A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.

  1996cited by this paper
• International Pancreas Transplant Registry report.

  1990cited by this paper

• The Nephrologist’s Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview

  2022cites this paper
• Combined Transplantation Liver-Heart, Lung, and/or Pancreas

  2021cites this paper
• Immunosuppression for pancreas allo-transplantation

  2020cites this paper
• Pancreas transplantation: Current issues, unmet needs, and future perspectives

  2020cites this paper
• Tacrolimus‐ versus sirolimus‐based immunosuppression after simultaneous pancreas and kidney transplantation: 5‐year results of a randomized trial

  2020cites this paper
• Pancreas grafts for transplantation from donors with hypertension: an analysis of the scientific registry of transplant recipients database

  2018cites this paper
• Pankreastransplantation – aktueller Stand und Probleme

  2017influential citation
• Pancreas Transplantation: Past, Present, Future.

  2016cites this paper
• Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions

  2014cites this paper
• Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature

  2014cites this paper
• Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin

  2014influential citation
• Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective

  2014cites this paper
• Trends in immunosuppression after pancreas transplantation: what is in the pipeline?

  2013cites this paper
• Kidney, Pancreas and Islet Transplant Options for Patients with Diabetic Nephropathy

  2013cites this paper
• Perspektiven der kombinierten Pankreas-Nieren-Transplantation

  2013cites this paper
• Impact of Tacrolimus-Sirolimus Maintenance Immunosuppression on Proteinuria and Kidney Function in Pancreas Transplant Alone Recipients

  2012cites this paper
• Simultaneous pancreas and kidney transplantation in diabetes with renal failure: the gold standard?

  2012cites this paper
• Transplantation of the Pancreas

  2012cites this paper
• Early findings of prospective anti‐HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience

  2012cites this paper
• Charcot Neuroarthropathy After Simultaneous Pancreas-Kidney Transplant

  2012cites this paper
• Effective therapy for acute antibody-mediated rejection with mild chronic changes: case report and review of the literature.

  2012cites this paper
• The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

  2012influential citation
• 19 Kidney-Pancreas Transplantation

  2012cites this paper
• Curing diabetes with transplantation?

  2012cites this paper
• Combined Pancreas and Kidney Transplantation or Kidney Alone Transplantation for Patients with Diabetic Nephropathy

  2012cites this paper
• Chapter 47 – Pancreas and Islet Cell Transplantation

  2012cites this paper
• Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation

  2011cites this paper
• Kidney-Pancreas Transplantation

  2011cites this paper
• Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Pancreas Transplantation

  2011cites this paper
• Present Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus

  2011cites this paper
• Improvement of the Immunoisolation Capacity of PEG Hydrogels through Bioactive Modifications

  2011cites this paper
• Immunosuppression in Simultaneous Pancreas-Kidney Transplantation

  2010cites this paper
• Pancreas transplantation.

  2009cites this paper
• Pankreastransplantation Schwerpunkt: Leber- und Pankreastransplantation

  2009cites this paper
• Antibody‐mediated rejection (AMR) after pancreas and pancreas–kidney transplantation

  2009cites this paper
• Islet and Pancreas Transplantation

  2009cites this paper